全球電子處方箋市場規模、佔有率、趨勢和成長分析報告（2026-2034）

電子處方箋市場預計將從 2025 年的 61.2 億美元成長到 2034 年的 533.8 億美元，預計從 2026 年到 2034 年將以 27.21% 的複合年成長率成長。

隨著醫療機構採用數位化解決方案來改善處方箋管理，全球電子處方箋市場正在快速成長。電子處方箋系統使醫生能夠創建處方箋並以電子方式發送給藥房，從而減輕行政負擔並最大限度地減少用藥錯誤。這些系統有助於提高醫療運作效率並改善病患安全。

多種因素正在推動電子處方箋市場的成長。政府推行的數位化醫療系統和電子健康記錄舉措，促進了電子處方箋解決方案的普及。此外，減少處方錯誤和改善藥物追蹤的需求日益成長，也進一步強化了對這些技術的需求。

隨著醫療系統數位化的推進，電子處方箋市場預計將持續成長。與電子健康記錄和藥房管理系統的整合將進一步提升系統功能。隨著醫療服務提供者致力於改善患者照護和提升營運效率，電子處方箋解決方案將繼續發揮至關重要的作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球電子處方箋市場：依產品分類

• 市場分析、洞察與預測
• 解決方案（整合解決方案、獨立解決方案）
• 服務（支援、實施、培訓、網路）

第5章：全球電子處方箋市場：以交付方式分類

• 市場分析、洞察與預測
• 基於Web/雲端
• 現場

第6章 全球電子處方箋市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院
• 實踐者
• 藥局

第7章 全球電子處方箋市場：依使用方法分類

• 市場分析、洞察與預測
• 攜帶式的
• 基於電腦的設備

第8章：全球電子處方箋市場：依成分分類

• 市場分析、洞察與預測
• 管制物質
• 不受監管的物質

第9章：全球電子處方箋市場：依專科分類

• 市場分析、洞察與預測
• 腫瘤學
• 運動醫學
• 神經病學
• 循環系統
• 其他

第10章 全球電子處方箋市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第11章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第12章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Cerner Corporation（Oracle）
  • Allscripts Healthcare LLC
  • Epic Systems Corporation
  • DrFirst
  • Athenahealth
  • NXGN Management LLC
  • McKesson Corporation
  • Surescripts
  • Change Healthcare
  • Practice Fusion Inc
  • Networking Technology Inc.（RXNT）

The E-Prescribing Market size is expected to reach USD 53.38 Billion in 2034 from USD 6.12 Billion (2025) growing at a CAGR of 27.21% during 2026-2034.

The global e-prescribing market has grown rapidly as healthcare providers adopt digital solutions to improve prescription management. E-prescribing systems allow physicians to generate and send prescriptions electronically to pharmacies, reducing paperwork and minimizing medication errors. These systems improve efficiency in healthcare operations and enhance patient safety.

Several factors are driving the growth of the e-prescribing market. Government initiatives promoting digital healthcare systems and electronic medical records are encouraging the adoption of electronic prescribing solutions. Additionally, the increasing need to reduce prescription errors and improve medication tracking has strengthened demand for these technologies.

Looking ahead, the e-prescribing market is expected to expand as healthcare systems continue to digitize medical processes. Integration with electronic health records and pharmacy management systems will enhance system functionality. As healthcare providers focus on improving patient care and operational efficiency, electronic prescribing solutions will remain essential tools.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Solutions (Integrated Solutions, Standalone Solutions)
• Services (Support, Implementation, Training, Network)

By Delivery Mode

• Web/Cloud-Based
• On-premise

By End-use

• Hospital
• Office-based Physicians
• Pharmacy

By Usage Methods

• Handheld
• Computer Based Devices

By Substances

• Controlled Substances
• Non-controlled Substances

By Specialties

• Oncology
• Sports Medicine
• Neurology
• Cardiology
• Others

COMPANIES PROFILED

• Cerner Corporation Oracle, Allscripts Healthcare LLC, Epic Systems Corporation, DrFirst, Athenahealth, NXGN Management LLC, McKesson Corporation, Surescripts, Change Healthcare, Practice Fusion Inc, Networking Technology Inc RXNT
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL E-PRESCRIBING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Solutions (Integrated Solutions, Standalone Solutions) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Services (Support, Implementation, Training, Network) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL E-PRESCRIBING MARKET: BY DELIVERY MODE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Delivery Mode
• 5.2. Web/Cloud-Based Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. On-premise Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL E-PRESCRIBING MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospital Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Office-based Physicians Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Pharmacy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL E-PRESCRIBING MARKET: BY USAGE METHODS 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Usage Methods
• 7.2. Handheld Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Computer Based Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL E-PRESCRIBING MARKET: BY SUBSTANCES 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Substances
• 8.2. Controlled Substances Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Non-controlled Substances Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL E-PRESCRIBING MARKET: BY SPECIALTIES 2022-2034 (USD MN)

• 9.1. Market Analysis, Insights and Forecast Specialties
• 9.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.3. Sports Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.4. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.5. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL E-PRESCRIBING MARKET: BY REGION 2022-2034(USD MN)

• 10.1. Regional Outlook
• 10.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.2.1 By Product
  • 10.2.2 By Delivery Mode
  • 10.2.3 By End-use
  • 10.2.4 By Usage Methods
  • 10.2.5 By Substances
  • 10.2.6 By Specialties
  • 10.2.7 United States
  • 10.2.8 Canada
  • 10.2.9 Mexico
• 10.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.3.1 By Product
  • 10.3.2 By Delivery Mode
  • 10.3.3 By End-use
  • 10.3.4 By Usage Methods
  • 10.3.5 By Substances
  • 10.3.6 By Specialties
  • 10.3.7 United Kingdom
  • 10.3.8 France
  • 10.3.9 Germany
  • 10.3.10 Italy
  • 10.3.11 Russia
  • 10.3.12 Rest Of Europe
• 10.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.4.1 By Product
  • 10.4.2 By Delivery Mode
  • 10.4.3 By End-use
  • 10.4.4 By Usage Methods
  • 10.4.5 By Substances
  • 10.4.6 By Specialties
  • 10.4.7 India
  • 10.4.8 Japan
  • 10.4.9 South Korea
  • 10.4.10 Australia
  • 10.4.11 South East Asia
  • 10.4.12 Rest Of Asia Pacific
• 10.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.5.1 By Product
  • 10.5.2 By Delivery Mode
  • 10.5.3 By End-use
  • 10.5.4 By Usage Methods
  • 10.5.5 By Substances
  • 10.5.6 By Specialties
  • 10.5.7 Brazil
  • 10.5.8 Argentina
  • 10.5.9 Peru
  • 10.5.10 Chile
  • 10.5.11 South East Asia
  • 10.5.12 Rest of Latin America
• 10.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.6.1 By Product
  • 10.6.2 By Delivery Mode
  • 10.6.3 By End-use
  • 10.6.4 By Usage Methods
  • 10.6.5 By Substances
  • 10.6.6 By Specialties
  • 10.6.7 Saudi Arabia
  • 10.6.8 UAE
  • 10.6.9 Israel
  • 10.6.10 South Africa
  • 10.6.11 Rest of the Middle East And Africa

Chapter 11. COMPETITIVE LANDSCAPE

• 11.1. Recent Developments
• 11.2. Company Categorization
• 11.3. Supply Chain & Channel Partners (based on availability)
• 11.4. Market Share & Positioning Analysis (based on availability)
• 11.5. Vendor Landscape (based on availability)
• 11.6. Strategy Mapping

Chapter 12. COMPANY PROFILES OF GLOBAL E-PRESCRIBING INDUSTRY

• 12.1. Top Companies Market Share Analysis
• 12.2. Company Profiles
  • 12.2.1 Cerner Corporation (Oracle)
  • 12.2.2 Allscripts Healthcare LLC
  • 12.2.3 Epic Systems Corporation
  • 12.2.4 DrFirst
  • 12.2.5 Athenahealth
  • 12.2.6 NXGN Management LLC
  • 12.2.7 McKesson Corporation
  • 12.2.8 Surescripts
  • 12.2.9 Change Healthcare
  • 12.2.10 Practice Fusion Inc
  • 12.2.11 Networking Technology Inc. (RXNT)